REED ELIZABETH E (CIK 1283303) reported 30 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-06). Recent activity: Buy TVTX (20,000 shares), Sell TVTX (20,000 shares), Buy TVTX (4,250 shares), Sell TVTX (2,174 shares), Sell TVTX (2,076 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 20,000 | $359,200 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 20,000 | $900,000 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 4,250 | $0 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 2,174 | $101,417 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 2,076 | $91,240 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 1,559 | $66,304 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 10,000 | $190,800 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 20,000 | $359,200 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 7,500 | $115,950 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 37,500 | $1.5M |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 14,000 | $0 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 5,226 | $217,506 |
| 2026-04-15 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 7,215 | $302,516 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 10,000 | $154,600 |
| 2026-04-02 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 10,000 | $300,000 |
| 2026-03-18 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 10,000 | $190,800 |
| 2026-03-18 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 10,000 | $280,900 |
| 2026-02-19 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 10,000 | $190,800 |
| 2026-02-19 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 5,679 | $156,172 |
| 2026-02-19 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 4,321 | $122,111 |
| 2026-02-05 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 2,485 | $79,694 |
| 2026-02-05 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 509 | $16,665 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 25,110 | $0 |
| 2026-02-03 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Sell | 7,175 | $230,461 |
| 2026-01-21 | Travere Therapeutics, Inc. (TVTX) | Chief Legal Officer and GC | Buy | 10,000 | $190,800 |
Source: SEC Form 4 filings · as of 2026-05-06